BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 3403273)

  • 1. [Differential diagnosis of Osler's telangiectasia and the CREST syndrome: significance of centromere antibodies].
    Stolz W; Ring J; Meurer M
    Hautarzt; 1988 Jun; 39(6):371-4. PubMed ID: 3403273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticentromere and anticentriole antibodies in the scleroderma spectrum.
    Tuffanelli DL; McKeon F; Kleinsmith DM; Burnham TK; Kirschner M
    Arch Dermatol; 1983 Jul; 119(7):560-6. PubMed ID: 6859899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
    Chen ZY; Fedrick JA; Pandey JP; Silver R; Maricq HR; Fudenberg HH; Dobson RL; Ainsworth SK
    Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-centromere antibody, biological marker of the CREST syndrome as distinct from scleroderma].
    Rouquette-Gally AM; Stern MH; Prost AC; Abuaf N; Homberg JC; Combrisson A
    Presse Med; 1985 Jul 13-20; 14(28):1497-500. PubMed ID: 2931679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anticentromere antibodies in rheumatoid polyarthritis with Sjögren syndrome, without the elements of the CREST syndrome].
    Lorcerie B; Tavernier C; Olsson O; Strauss J; Martin F
    Rev Rhum Mal Osteoartic; 1988 Mar; 55(4):291-2. PubMed ID: 3259719
    [No Abstract]   [Full Text] [Related]  

  • 6. [Centromere antibodies and antibodies against Scl 70 nucleoprotein in progressive systemic scleroderma. Diagnostic and prognostic significance].
    Meurer M; Scharf A; Luderschmidt C; Braun-Falco O
    Dtsch Med Wochenschr; 1985 Jan; 110(1):8-14. PubMed ID: 3880700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O; Haim T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticentromere antibodies: clinical and biological significance.
    Fritzler MJ; Ayer LM
    J Rheumatol; 1982; 9(4):489-90. PubMed ID: 6982333
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anticentromere antibodies. Diagnostic and prognostic value].
    Meyer O; Haïm T
    Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A long-term longitudinal study of anticentromere antibodies.
    Tramposch HD; Smith CD; Senecal JL; Rothfield N
    Arthritis Rheum; 1984 Feb; 27(2):121-4. PubMed ID: 6607733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
    Uchida K; Kondo H; Kashiwazaki S
    Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895
    [No Abstract]   [Full Text] [Related]  

  • 12. Anticentromere antibodies--clinical correlates.
    Wade JP; Sack B; Schur PH
    J Rheumatol; 1988 Dec; 15(12):1759-63. PubMed ID: 3265957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticentromere antibody and primary pulmonary hypertension.
    Seibold JR; Trontell MC
    J Rheumatol; 1982; 9(4):607-9. PubMed ID: 6752406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acrosclerosis, Gougerot-Sjögren syndrome, myxedema and anti-centromere antibodies. 3 cases of this association].
    Balafrej M; Kahn MF; Vigneron AM; Bourgeois P
    Ann Med Interne (Paris); 1987; 138(3):185-8. PubMed ID: 3497597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variants.
    McCarty GA; Rice JR; Bembe ML; Barada FA
    Arthritis Rheum; 1983 Jan; 26(1):1-7. PubMed ID: 6337593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anticentromere antibody, CREST and cancer].
    Boyeldieu D; Rouquette-Gally AM; Laugier A; Abuaf N
    Presse Med; 1987 Nov; 16(38):1924-5. PubMed ID: 2962150
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anti-centromere antibody (ACA) and its significance for the diagnosis of CREST syndrome].
    Chen SE; Gu YY; Xu YH
    Zhonghua Nei Ke Za Zhi; 1986 Dec; 25(12):736-8, 776. PubMed ID: 3494576
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The CREST syndrome associated with the sicca syndrome].
    González Perez JA; Calvo Catala J; Almela Requena JV; González-Cruz Cervellera A; Sospedra Lara EM; Hurtado Vicente MJ
    An Med Interna; 1989 Oct; 6(10):540-2. PubMed ID: 2491051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CREST syndrome: a distinct serologic entity with anticentromere antibodies.
    Fritzler MJ; Kinsella TD
    Am J Med; 1980 Oct; 69(4):520-6. PubMed ID: 6968511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.